HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype
- 1 April 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 103 (7), 2835-2840
- https://doi.org/10.1182/blood-2003-10-3366
Abstract
Hereditary hemochromatosis is a genetically heterogeneous disease of iron metabolism. The most common form of the disorder is an adult-onset form that has mainly been associated with the HFE pC282Y/pC282Y genotype. The phenotypic expression of this genotype is very heterogeneous and could be modulated by both environmental factors and modifier genes. The non-HFE hereditary hemochromatosis forms include a juvenile onset form associated with mutations in HAMP. From a cohort of 392 C282Y homozygous patients, we found 5 carriers of an additional HAMP mutation at the heterozygous state (pR59G, pG71D, or pR56X). We found that iron indices of these 5 patients were among the most elevated of the cohort. Moreover, we specified that the HAMP mutations were not detected in 300 control subjects. These results revealed that mutations in HAMP might increase the phenotypic expression of the pC282Y/pC282Y genotype. From a cohort of 31 patients with at least one chromosome lacking an HFE mutation, we further identified 4 males carrying a heterozygous HAMP mutation (pR59G or pG71D). Based on a digenic model of inheritance, these data suggest that the association of heterozygous mutations in the HFE and HAMP genes could lead, at least in some cases, to an adult-onset form of primary iron overload. (Blood. 2004;103:2835-2840)Keywords
This publication has 44 references indexed in Scilit:
- Longevity and carrying the C282Y mutation for haemochromatosis on the HFE gene: case control study of 492 French centenariansBMJ, 2003
- Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosisNature Genetics, 2003
- Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosisNature Genetics, 2003
- Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosisNature Genetics, 2002
- The Solution Structure of Human Hepcidin, a Peptide Hormone with Antimicrobial Activity That Is Involved in Iron Uptake and Hereditary HemochromatosisJournal of Biological Chemistry, 2002
- A Study of Genes That May Modulate the Expression of Hereditary Hemochromatosis: Transferrin Receptor-1, Ferroportin, Ceruloplasmin, Ferritin Light and Heavy Chains, Iron Regulatory Proteins (IRP)-1 and -2, and HepcidinBlood Cells, Molecules, and Diseases, 2001
- Idiopathic Hemochromatosis with the Mutation of Ala176Val Heterozygous for HFE Gene.Internal Medicine, 2001
- Contribution of different HFE genotypes to iron overload disease: a pooled analysisGenetics in Medicine, 2000
- Geography ofHFEC282Y and H63D MutationsGenetic Testing, 2000
- A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosisNature Genetics, 1996